NasdaqGM - Delayed Quote USD
Neurogene Inc. (NGNE)
19.76
-0.64
(-3.14%)
At close: June 13 at 4:00:00 PM EDT
19.76
0.00
(0.00%)
After hours: June 13 at 4:04:16 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 59,800 | 4 |
| Sales | 11,298 | 2 |
| Net Shares Purchased (Sold) | 48,502 | 6 |
| Total Insider Shares Held | 1.32M | -- |
| % Net Shares Purchased (Sold) | 3.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| COBB STUART Officer | Sale at price 15.15 per share. | Direct | 103,003 | May 14, 2025 |
| CVIJIC CHRISTINE MIKAIL President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2025 |
| MCMINN RACHEL L. PH.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2025 |
| JORDAN JULIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2025 |
| COBB STUART Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 26, 2025 |
| CVIJIC CHRISTINE MIKAIL President | Sale at price 16.94 per share. | Direct | 76,247 | Mar 13, 2025 |
| SAMSARA BIOCAPITAL GP, LLC Beneficial Owner of more than 10% of a Class of Security | Purchase at price 24.91 - 27.50 per share. | Indirect | 1,259,623 | Nov 26, 2024 |
| CVIJIC CHRISTINE MIKAIL President | Purchase at price 20.48 per share. | Direct | 491,400 | Nov 22, 2024 |
| MCMINN RACHEL L. PH.D. Chief Executive Officer | Purchase at price 20.40 per share. | Direct | 969,000 | Nov 22, 2024 |
| CVIJIC CHRISTINE MIKAIL President | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| COBB STUART Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 13, 2024 |
| BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | -- | Indirect | -- | Oct 5, 2023 |
| BAKER BROS ADVISORS L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase at price 0.63 - 0.69 per share. | Indirect | 1,463,487 | Aug 17, 2023 |
| SMITH SEAN MICHAEL Chief Financial Officer | Sale at price 0.62 per share. | Direct | 818 | Aug 11, 2023 |
| SMITH SEAN MICHAEL Chief Financial Officer | -- | Direct | -- | Aug 10, 2023 |
Related Tickers
TSHA Taysha Gene Therapies, Inc.
2.5400
-4.15%
RAPP Rapport Therapeutics, Inc.
11.19
+0.45%
CGEM Cullinan Therapeutics, Inc.
8.61
-3.80%
CNTA Centessa Pharmaceuticals plc
12.38
+2.82%
9EN.F Pharvaris N.V.
13.90
0.00%
QURE uniQure N.V.
15.34
-4.07%
DYN Dyne Therapeutics, Inc.
14.41
-0.35%
JBIO Jade Biosciences, Inc.
6.76
-2.59%
NRIX Nurix Therapeutics, Inc.
11.93
-0.25%
KRRO Korro Bio, Inc.
13.54
-3.15%